Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial.

MLA

Iida, Osamu, et al. “Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial.” Journal of Endovascular Therapy : An Official Journal of the International Society of Endovascular Specialists, vol. 26, no. 2, Apr. 2019, pp. 158–67. EBSCOhost, https://doi.org/10.1177/1526602819826591.

APA

Iida, O., Urasawa, K., Komura, Y., Soga, Y., Inoue, N., Hara, H., Yajima, J., Nakamura, S., Ohki, T., Ando, H., Hirano, K., Horita, Y., Kichikawa, K., Yokoi, Y., Miyamoto, A., Nakamura, M., Takahara, M., Mano, T., & Nanto, S. (2019). Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial. Journal of Endovascular Therapy : An Official Journal of the International Society of Endovascular Specialists, 26(2), 158–167. https://doi.org/10.1177/1526602819826591

Chicago

Iida, Osamu, Kazushi Urasawa, Yasuo Komura, Yoshimitsu Soga, Naoto Inoue, Hidehiko Hara, Junji Yajima, et al. 2019. “Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial.” Journal of Endovascular Therapy : An Official Journal of the International Society of Endovascular Specialists 26 (2): 158–67. doi:10.1177/1526602819826591.